Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle

Manisha Sinha(Joslin Diabetes Center), Young C. Jang(Joslin Diabetes Center), Juhyun Oh(Joslin Diabetes Center), Danika Khong(Joslin Diabetes Center), Elizabeth Y. Wu(Joslin Diabetes Center), Rohan Manohar(Joslin Diabetes Center), Christine Miller(Joslin Diabetes Center), Samuel G. Regalado(Harvard Stem Cell Institute), Francesco S. Loffredo(Brigham and Women's Hospital), James R. Pancoast(Brigham and Women's Hospital), Michael F. Hirshman(Joslin Diabetes Center), Jessica Lebowitz(Joslin Diabetes Center), Jennifer L. Shadrach(Joslin Diabetes Center), Massimiliano Cerletti(Joslin Diabetes Center), Mi Jeong Kim(Joslin Diabetes Center), Thomas Serwold(Joslin Diabetes Center), Laurie J. Goodyear(Brigham and Women's Hospital), Bernard Rosner(Harvard University), Richard Lee(Brigham and Women's Hospital), Amy J. Wagers(Joslin Diabetes Center)
Science
May 5, 2014
Cited by 829Open Access
Full Text

Abstract

Parabiosis experiments indicate that impaired regeneration in aged mice is reversible by exposure to a young circulation, suggesting that young blood contains humoral "rejuvenating" factors that can restore regenerative function. Here, we demonstrate that the circulating protein growth differentiation factor 11 (GDF11) is a rejuvenating factor for skeletal muscle. Supplementation of systemic GDF11 levels, which normally decline with age, by heterochronic parabiosis or systemic delivery of recombinant protein, reversed functional impairments and restored genomic integrity in aged muscle stem cells (satellite cells). Increased GDF11 levels in aged mice also improved muscle structural and functional features and increased strength and endurance exercise capacity. These data indicate that GDF11 systemically regulates muscle aging and may be therapeutically useful for reversing age-related skeletal muscle and stem cell dysfunction.


Related Papers